Thus, the clinical interpretation of plasma biomarker levels in cases of concurrent EI should be cautious and involve multiple analytes, since S100B levels may be falsely elevated because of ethanol itself (or because of additional conditions such as neoplastic disorders, e.g. [66]) and NSE levels may be reduced because of a protective effect of ethanol. The gene discussed is S100B; the disease is neoplastic disease or syndrome.